Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

22. Oktober 2025 07:03 ET | Quelle: Research and Markets

Age-Related Macular Degeneration (AMD) Pipeline Market Research 2025: Opportunities Via Emerging Novel Therapies Focusing on Innovative Mechanisms

Dublin, Oct. 22, 2025 (GLOBE NEWSWIRE) -- The "Age-Related Macular Degeneration (AMD) - Pipeline Insight, 2025" has been added to ResearchAndMarkets.com's offering. The "Age-Related Macular...
22. November 2024 07:10 ET | Quelle: Research and Markets

Wet Age-Related Macular Degeneration (Wet AMD) Pipeline Landscape Research 2024

Dublin, Nov. 22, 2024 (GLOBE NEWSWIRE) -- The "Wet Age-Related Macular Degeneration (Wet AMD) - Pipeline Insight, 2024" report has been added to ResearchAndMarkets.com's offering. The emergent...
08. November 2024 11:26 ET | Quelle: Research and Markets

Age-Related Macular Degeneration (AMD) Drugs Market Research 2024: Lucentis, Eylea, Eylea HD, Vabysmo, Syfovre, Ranibizumab, Aflibercept, Faricimab, Biologic, Biosimilar - Global Forecast to 2029

Dublin, Nov. 08, 2024 (GLOBE NEWSWIRE) -- The "Age-Related Macular Degeneration (AMD) Drugs Market by Product (Lucentis, Eylea & Eylea HD, Vabysmo, Syfovre), Molecule (Ranibizumab, Aflibercept,...
01. März 2024 08:54 ET | Quelle: Research and Markets

Dry Age-related Macular Degeneration (Dry-AMD) Drug Pipeline Insight Landscape Report 2024: Comprehensive Insights About 70+ Companies and 80+ Pipeline Drugs

Dublin, March 01, 2024 (GLOBE NEWSWIRE) -- The "Dry Age-related Macular Degeneration (Dry-AMD) - Pipeline Insight, 2024" clinical trials has been added to ResearchAndMarkets.com's offering.This...